Chemotherapy-related acute rhabdomyolysis.
Papakonstantinou
C
C
Papanastasiou
K
K
Kotsopoulou
M
M
Mouratidou
M
M
Sotiropoulos
D
D
Kyrtsoni
M C
MC
Pouli
A
A
Stamatelou
M
M
Maniatis
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D008775:Methylprednisolone / Q000009:adverse effects; D008875:Middle Aged; D011239:Prednisolone / Q000009:adverse effects; D012206:Rhabdomyolysis / Q000139:chemically induced*; D013866:Thioguanine / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D013866:Thioguanine; D008775:Methylprednisolone